{"id":"W4399414899","doi":"10.1093/jjco/hyae048","title":"Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021–22","year":2024,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Medicine; Atezolizumab; Bevacizumab; Regimen; Lenvatinib; Sorafenib; Internal medicine; Hepatocellular carcinoma; Oncology; Systemic therapy; First line treatment; Cost effectiveness; Cancer; Chemotherapy; Nivolumab; Breast cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008713357,0.0004998456,0.0004497746,0.001448771,0.000305806,0.001387449,0.0005137858,0.0004018804,0.002114368],"category_scores_gemma":[0.002213442,0.0002496266,0.000959671,0.003050467,0.0003081835,0.0008710748,0.000492184,0.0004046872,0.0002324511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003602398,"about_ca_system_score_gemma":0.002876377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05321576,"about_ca_topic_score_gemma":0.05097497,"domain_scores_codex":[0.9994563,0.0001589853,0.0001127307,0.00005887548,0.0001391155,0.00007391247],"domain_scores_gemma":[0.9980429,0.0001531053,0.000995348,0.00003862261,0.0005550663,0.00021488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007463073,0.0001260181,0.7927241,0.00194286,0.001196159,0.0005058304,0.0002793746,0.003401292,0.0007657898,0.001491999,0.02622692,0.1705934],"study_design_scores_gemma":[0.00004185084,0.0001194651,0.9732916,0.0004942692,0.0005109916,0.0006079664,0.0007072511,0.003255124,0.0001807563,0.000346486,0.02041164,0.00003249663],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7403522,0.2085819,0.001398687,0.01789303,0.0005624086,0.00006336105,0.01693602,0.00008751961,0.01412485],"genre_scores_gemma":[0.9290383,0.05337465,0.001445085,0.000973977,0.0004836925,0.00007419692,0.01347248,0.00002051774,0.001117084],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05321576,"threshold_uncertainty_score":0.1058121,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09808055652630598,"score_gpt":0.378300364594102,"score_spread":0.280219808067796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}